Dr. Peush Bajpai

Major Cancer Types Treated

• Breast Cancer
• Gynaecological Cancers (Ovarian, Uterine, Cervical)
• Haematological Malignancies: Lymphoma, Leukaemia (CML, ALL), Multiple Myeloma
• Gastrointestinal Cancers (Colorectal, Gastric, Pancreatic, Hepatobiliary)
• Lung Cancer
• Prostate Cancer
• Soft Tissue Sarcomas

Sub-specialties

• Medical Oncology
• Breast Oncology (Medical)
• Gynae-Oncology (Medical)
• Hemato-oncology
• Precision and Molecular Oncology
• Immuno-Oncology

Advanced Procedures Performed

• Immunotherapy (including immune checkpoint inhibitors)
• Targeted Therapy (based on molecular markers)
• Precision Medicine: NGS interpretation, biomarker-guided therapy (HRD/TMB/MSI-based)
• Advanced Chemotherapy Regimens
• Hormonal Therapy

Current & Past Hospital Affiliations

• Current Affiliations: Director & Unit Head - Medical Oncology, Max Hospital, Dwarka, New Delhi
• Past Affiliations:
  • HOD – Medical & Hemato-Oncology, Manipal Hospital, Dwarka, New Delhi
  • Senior Consultant, Max Super Speciality Hospital, Shalimar Bagh, New Delhi
  • Consultant, BLK Super Speciality Hospital, New Delhi
  • Senior Registrar/Registrar, Cancer Institute (WIA), Adyar, Chennai

Academic & Research Roles

• DM Dissertation Thesis: "Prospective evaluation of musculoskeletal events in patients of CML – chronic phase treated with Imatinib AND possible correlation with electrolyte imbalances".
• MD Dissertation Thesis: "Lifestyle risk factors in Gastro-oesophageal reflux disease".

Key Achievements & Contributions

• Member of prestigious international oncology societies including the American Society of Clinical Oncology (ASCO) and the European Society of Medical Oncology (ESMO).
• Led the comprehensive Breast Cancer Management program at Manipal Hospital, Delhi.

National & International Awards

• First Prize: As part of a team in a Case Presentation at the Indo UK Breast Oncoplasty Masterclass (2016).
• First Prize: In the All India Quiz at the Lymphoma & Leukaemia meet in Mumbai, organised by ESMO (2012).
• Best Poster Award: At BTG Hong Kong for his research on "Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances".

Published Papers in Medical Journals

• Management of Metastatic Colorectal Cancer (mCRC): RealWorld Recommendations (South Asian Journal of Cancer, 2024)
• Collusion: The facade and its implications on total pain management in palliative care (Indian Journal of Palliative Care, 2022)
• Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response (Journal of Gastrointestinal Cancer, 2019)
• Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy (South Asian Journal of Cancer, 2019)
• A rare case of peripheral T-cell lymphoma in one year old child (Indian Journal of Medical and Paediatric Oncology, 2011)
• Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline (Indian Journal of Hematology and Blood Transfusion, 2014)
• Rare case of hairy cell leukemia in a patient of head and neck malignancy (The Tamil Nadu Dr. M.G.R. Medical University, Journal of Medicine, 2012)

Notable Cases Handled

• Expert in managing complex and refractory breast and gynaecological cancers using precision medicine and novel drug combinations.
• Successfully treated numerous patients with Chronic Myeloid Leukaemia (CML) and other blood cancers, with a special research focus on managing treatment side effects.
• Pioneered the use of immunotherapy and targeted therapy in real-world settings in India for various solid tumours.

Patient Testimonials

• "Dr. Peush Bajpai is a true expert in breast cancer. He recommended a treatment based on my tumour’s genetic markers, which was far more effective with fewer side effects. His approach is modern, scientific, and deeply reassuring. I am in remission today because of him." - Sunita Sharma
• "My father was diagnosed with advanced lymphoma, and we were fortunate to find Dr. Bajpai. He is not just an amazing doctor but also a great motivator. He won a quiz on lymphoma, and his knowledge truly reflects that. We felt we were in the safest hands." - Ankit Gupta
• "I was diagnosed with ovarian cancer, and Dr. Bajpai handled my case with immense sensitivity and expertise. He is always updated on the latest therapies and made me feel like a partner in my own treatment plan. A truly wonderful and knowledgeable oncologist." - P. Desai

Patient-Centred Care
Dr. Bajpai is dedicated to providing personalised and evidence-based cancer care. He believes in a holistic approach, considering the patient's physical, emotional, and molecular profile to design the most effective treatment strategy. He ensures that patients and their families are well-informed and empowered throughout their cancer journey.

Technology & Innovation
With a keen and avid interest in Molecular Oncology and Precision Medicine, Dr. Bajpai is a strong proponent of using advanced diagnostics like Next-Generation Sequencing (NGS) to guide treatment. He specialises in interpreting complex molecular reports to select the most appropriate Targeted Therapies and Immunotherapies, moving beyond the one-size-fits-all approach to deliver truly personalised cancer care.

Note: The costs mentioned are indicative. For a precise cost estimate and consultation fee, please connect with the Cancer Rounds team.

Language Support
The Cancer Rounds team offers professional interpretation services to ensure clear and seamless communication for international patients and their families.

Visa & Travel Assistance
Our dedicated international patient services team provides comprehensive support with medical visa processes, travel logistics, airport transfers, and arranging suitable accommodation.

Pre-treatment Virtual Consultations
Dr. Peush Bajpai is available for online video consultations to provide second opinions, review medical reports, and discuss a potential treatment strategy before your travel to India.